SCHEMBL188484

SCHEMBL188484

CC(C)C1CCOC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21005928 1.00
SCHEMBL2738308 1.00
SCHEMBL10077981 0.86 PIK3CD (0.36)
SCHEMBL6547132 0.85 PIK3CD (0.35)
SCHEMBL3994535 0.82
SCHEMBL13986494 0.79 KDM4E (0.33)
SCHEMBL22696465 0.79 POLB (0.33)
SCHEMBL21005918 0.79 KDM4E (0.33)
SCHEMBL13986498 0.79 KDM4E (0.33)
SCHEMBL15277286 0.77 POLB (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102370242-B A kind of grouping method of tobacco raw material leaf component HONGTA TOBACCO (GROUP) CO., LTD. (CN) 2015-08-19 CN claimed
CN-102370242-A Grouping method of tobacco raw material leaf component HONGTA TOBACCO GROUP CO LTD 2012-03-14 CN claimed
EP-4003314-B1 FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS USEFUL FOR THE PREVENTION OR TREATMENT OF DISEASE ESPERVITA THERAPEUTICS INC (US) 2024-07-10 EP disclosed
US-20230303599-A1 PRODRUGS OF PHOSPHONAMIDE NUCLEOTIDE ANALOGUES AND THEIR PHARMACEUTICAL USE GILEAD SCIENCES, INC. 2023-09-28 US disclosed
US-20230278952-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2023-09-07 US disclosed
US-20230278952-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2023-09-07 US disclosed
US-20230272010-A1 ANTIBACTERIAL SYNTHETIC-BIOINFORMATIC NATURAL PRODUCTS AND USES THEREOF UNIV ROCKEFELLER (US) 2023-08-31 US disclosed
US-11737995-B2 Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease ESPERVITA THERAPEUTICS, INC. (US) 2023-08-29 US disclosed
US-11730712-B2 Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease ESPERVITA THERAPEUTICS, INC. (US) 2023-08-22 US disclosed
US-20230206644-A1 PYRAZOLOPYRIMIDINE COMPOUNDS AS JAK INHIBITORS GENENTECH, INC. (US) 2023-06-29 US disclosed
US-20230150976-A1 4-Amino Pyrimidine Compounds for the Treatment of Cancer UNIVERSITY OF ROCHESTER (US) 2023-05-18 US disclosed
US-20070219206-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-09-20 US disclosed
US-20070161685-A1 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2007-07-12 US disclosed
US-20070135631-A1 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2007-06-14 US disclosed
EP-1756172-A2 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia S.r.l. (IT) 2007-02-28 EP disclosed
WO-2007014839-A2 CATHEPSIN K INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-02-08 WO disclosed
WO-2005123784-A2 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2005-12-29 WO disclosed
EP-0229007-B1 ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES WASHINGTON UNIVERSITY (US) 1990-11-28 EP disclosed
US-4707491-A Anticonvulsant γ-thiobutyrolactone derivatives WASHINGTON UNIVERSITY (US) 1987-11-17 US disclosed
EP-0229007-A1 Anticonvulsant gamma-thiobutyrolactone derivatives WASHINGTON UNIVERSITY (US) 1987-07-15 EP disclosed